JASON E KNUFFMAN

Allopathic & Osteopathic Physicians|Internal Medicine|Allergy & Immunology QUINCY, IL NPI 1184690109

General Payments — all program years on this page

$933.25

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $380.62 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $307.8716
Education $72.752

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GlaxoSmithKline, LLC. $100.815
Acerta Pharma LLC $74.474
SANOFI-AVENTIS U.S. LLC $57.481
CSL Behring $53.153
Regeneron Healthcare Solutions, Inc. $51.612
GENZYME CORPORATION $27.832
PFIZER INC. $15.271

By program year

Program yearAmountRecords
2018 $184.002
2019 $50.081
2021 $106.044
2022 $84.725
2023 $127.797
2024 $380.6218

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104350186 AstraZeneca Pharmaceuticals LP $19.59 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105298278 AstraZeneca Pharmaceuticals LP $19.41 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105400376 AstraZeneca Pharmaceuticals LP $16.81 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105854676 AstraZeneca Pharmaceuticals LP $18.66 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114090019 Regeneron Healthcare Solutions, Inc. $24.96 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114090021 Regeneron Healthcare Solutions, Inc. $26.65 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116238796 GlaxoSmithKline, LLC. $20.75 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116373536 GlaxoSmithKline, LLC. $17.87 09/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116386066 GlaxoSmithKline, LLC. $16.52 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116501797 GlaxoSmithKline, LLC. $28.16 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116567146 GlaxoSmithKline, LLC. $17.51 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131828236 PFIZER INC. $15.27 04/10/2024 Education Undisputed 01/23/2026 View at CMS
1134628677 CSL Behring $25.26 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134628687 CSL Behring $14.50 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134628699 CSL Behring $13.39 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139623339 GENZYME CORPORATION $13.88 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139623361 GENZYME CORPORATION $13.95 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139623411 SANOFI-AVENTIS U.S. LLC $57.48 10/30/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.